A 4-week, double-blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptom evaluation in healthy volunteers

Revmatologiia

Volumn 35, Issue SUPPL. 1, 1996, Pages 61-67

  Patoia, L ^a   Santucci, L ^a   Furno, P ^a   Dionisi, M S ^a   Dell'Orso, S ^b   Romagnoli, M ^a   Sattarinia, A ^a   Marini, M G ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Boehringer Ingelheim Italia SpA   (Italy)

Author keywords

Faecal blood loss; Gastrointestinal endoscopy; Meloxicam; Piroxicam

Indexed keywords

MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN SYNTHASE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; ENZYME INHIBITION; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OCCULT BLOOD; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIGESTIVE SYSTEM; DOUBLE-BLIND METHOD; DRUG EVALUATION; DRUG TOLERANCE; ENDOSCOPY, GASTROINTESTINAL; HUMANS; MALE; OCCULT BLOOD; PIROXICAM; THIAZINES; THIAZOLES; TIME FACTORS;

EID: 0029866403     PISSN: 13100505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Langman MJS, Weil J, Wainwright P et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:1075-8.
2. Lanza FL. Gastrointestinal toxicity of newer NSAIDs. Am J Gastroenterol 1993;88:1318-23.
3. Garcia Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343: 769-72.
4. Del Favero A. Antiinflammatory analgesics and drugs used in rheumatoid arthritis and gout. In: Dukes MNG, Aronson JK, eds. Side effects of drugs: Elsevier, Amsterdam, Annual 1992; 16.
5. Del Favero A, Patoia L, Santucci L. The evaluation of acute gastrointestinal toxicity of NSAIDs in phase I clinical trials: a critical appraisal. Side effects of anti-inflammatory drugs 3. In: Rainsford KD, Velo GP, eds. Kluwer, Netherlands. Inflammation and Drug Therapy Series. 1992;Vol. V.
6. Santucci L, Patoia L, Fiorucci S, Farroni F, Del Favero A, Morelli A. Oesophageal lesions during treatment with piroxicam. Br Med J 1990;300:1018.
7. Engelhardt G. Meloxicam, a potent inhibitor of COX-2. Data presented at 9th International Conference on Prostaglandins and Related Compounds. Florence, Italy, 6-10 June 1994, p. 82.
8. Engelhardt G, Homma D, Schlegel K, Utzmann R, Schnitzler Chr. Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance. Inflamm Res 1995;44:423-33.
9. Wojtulewski JA, Schattenkirchner M, Barceló P et al. A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis. Br J Rheumatol 1996;35(suppl. 1):22-28.
10. Lindén B, Distel M, Bluhmki E. A double-blind study to compare the efficacy and safety of meloxicam 15 mg with piroxicam 20 mg in patients with osteoarthritis of the hip. Br J Rheumatol 1995;35(suppl. 1):35-8.
11. Hosie J, Distel M, Bluhmki E. Meloxicam in osteoarthritis: a 6-month, double-blind comparison with diclofenac sodium. Br J Rheumatol 1995;35(suppl. 1):39-43.
12. Frenkel EP, McCall MS, Douglass CC, Eisenberg S. Faecal blood loss following aspirin and coated aspirin microspherule administration. J Clin Pharmacol J New Drugs 1968;8:347-51.
13. Lanza F, Panagides J, Salom IL. Etodolac compared with aspirin: an endoscopic study of the gastrointestinal tracts of normal volunteers. J Rheumatol 1986;13:299-303.
14. Salom IL, Jacob G, Jallad N, Perdomo CA, Mullane JF, Weidler D. Gastrointestinal microbleeding associated with the use of etodolac, ibuprofen, indomethacin and naproxen in normal males. J Clin Pharmacol 1985;24:240-6.
15. Gillings D, Koch H. The application of the principle of intention to treat to the analysis of clinical trials. Drug Inf J 1992;25:411-24.
16. Tukey JW. Comparing individual means in the analysis of variance. Biometrics 1949;5:99-114
17. Conover WJ. Rank transformations as a bridge between parametric and non parametric statistics. Am Stat 1981;35:124-8.
18. Lund B, Distel M, Bluhmki E. A double-blind, placebo-controlled study of three different doses of meloxicam in patients with osteoarthritis (OA) of the knee. Scand J Rheum 1994;Suppl 98:abstract no. 117.